Share on Instagram  
Background Image

#iconohash presents #BCSM

Scroll down for the #BCSM conversation report for August 12th, 2018 EST.

iconohash

the world's conversation archive

#BCSM for August 12th, 2018EST

01
51st

coming together

When it comes to participants, we ranked 51st among 436 conversations.

51st

participating

In terms of the number of posts, we ranked 51st out of 436 conversations that took place.

28th

amplification

This conversation ranked 28th out of 436 in terms of the amplification of ideas & content.

how we participated. Here's how participants reacted & engaged each other

Reactions
78%

Amplified

There were 51 reshares, 78% of posts, during the course of the conversation.

0%

Engaged

0% of participants in this conversation engaged each other 0 times.

68%

Content

68% of participants in this conversation shared a total of 10 unique pieces of content.

quick facts.

Here are the basic facts of the conversation for for August 12th, 2018.

0
Active
Participants
0
Posts
Total

meet the influencers the movers and shakers of #BCSM

02

the top of the list. Top influencers in the chat

IMPACT
@stales

@stales

Alicia C. Staley
Co-founder of #BCSM, POWER TWEETER, eternal optimist, 3x cancer survivor #MedX #ASBrS #ASCO #SABCS #PatientDriven - Sr. Dir of Patient Engagement @Medidata

@JAMAOnc

@JAMAOnc

JAMA Oncology
JAMA #Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology.

@BreastAdvocate

@BreastAdvocate

Breast Advocate
Free #BreastCancer #Surgery #SharedDecisionMaking App for #Survivors, #Thrivers and #Previvors. Co-created by breast cancer specialists and patient advocates.

about the participants. let's take a look at everyone who show'd up

03

top professions what are they doing when they're not in #BCSM

insight

  the top participating professions
out of 15 total

oncologist
research
founder
director
blogger

gender an estimation of what the gender break down looks like
= 1 men or women

insight

Women

Men

about the content. the best content that was shared

04
EU Approves Trastuzumab Biosimilar for HER2+ Breast, Gastric Cancers
PF-05280014 (Trazimera), a biosimilar for trastuzumab (Herceptin), has been approved for use in the European Union to treat patients with HER2 overexpressing metastatic or early breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.

chat growth how is #BCSM growing over time?

05

want more? are you interested in the full data analysis for this chat? Full transcript? Longer view at chat growth?

Email us today at research@iconohash.com or schedule a tour of our custom reports. We'll be happy to work with you. We can provide the raw data or custom reports on a scheduled basis. Full data analysis includes in-depth profile data, chat growth analysis, chat reach, influence reach, location profiles, and content profiles. Full reports are delivered via sharable web-based reports or beautiful PDFs, if you prefer to print and distribute.